Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Corrections & Clarifications

"Make-or-Break Time for Cancer Drugs" (Personal Business, June 8, 2009)


"Make-or-Break Time for Cancer Drugs" (Personal Business, June 8, 2009) mistakenly said that biotech company Celgene has a forthcoming treatment for hepatitis C. Celgene is not focusing on this disease.

LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus